Bafna Pharmaceuticals launches RARICAP injection in domestic market

20 Nov 2013 Evaluate

Bafna Pharmaceuticals, a Chennai-based Pharma company, has launched RARICAP in injection form as RARICAP S in domestic market. This is another product in women wellness segment for Iron Deficiency Anaemia during Pregnancy and also for Anaemia in Chronic Kidney Disease.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

77.23 -1.77 (-2.24%)
30-Apr-2025 15:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1831.10
Dr. Reddys Lab 1183.40
Cipla 1550.85
Lupin 2101.85
Zydus Lifesciences 889.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...